Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus.
about
Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosusRelative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.Considerations for clinical pharmacology studies for biologics in emerging markets.Belimumab in the management of systemic lupus erythematosus - an update.Drug Development of Therapeutic Monoclonal Antibodies.Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus.Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies.Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program.Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus.Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.
P2860
Q36806630-78649C68-6A0E-4C9F-B652-F5C764445BA7Q37337375-47A9564B-A4F3-424F-BA1E-2152FA55DCC1Q38364458-855CC013-0959-4FA9-A47B-F9B1FF36C06FQ38810737-F5A466A4-B8AC-4ACE-8DC8-3D53358673DAQ38876360-E2804127-1869-41C2-BA6A-DA639CBB1B6AQ38888137-21C4F824-26DC-4DB9-A5DF-7190116EB490Q38987211-23A34934-4442-4F73-A4B9-BB55337D0D0CQ39855585-5D9DFBAD-9A15-451E-A4BF-1FA6CE36B887Q48010137-8D08F558-AEFF-4B4A-BE15-A31A85C9C007Q55267717-49DACA57-B8DD-4325-AF28-3125A4EAFDED
P2860
Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Population pharmacokinetics of ...... systemic lupus erythematosus.
@en
Population pharmacokinetics of ...... systemic lupus erythematosus.
@nl
type
label
Population pharmacokinetics of ...... systemic lupus erythematosus.
@en
Population pharmacokinetics of ...... systemic lupus erythematosus.
@nl
prefLabel
Population pharmacokinetics of ...... systemic lupus erythematosus.
@en
Population pharmacokinetics of ...... systemic lupus erythematosus.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... systemic lupus erythematosus.
@en
P2093
Cecil Chen
Herbert Struemper
P2860
P304
P356
10.1002/JCPH.104
P577
2013-05-16T00:00:00Z